S
Sutro Biopharma D
D
STRO
25.380
USD
2.86
(12.70%)
مغلق
حجم التداول
9,948
الربح لكل سهم
-5
العائد الربحي
-
P/E
-1
حجم السوق
414,938,463
العنوان: Sutro Biopharma Inc.
القطاع: Healthcare
الصناعة: Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancerand autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.